Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

10.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

15.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

10.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.5K
Coagulation01:09

Coagulation

11.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
11.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Role of Polyphenols in Platelet Aggregation and Blood Coagulation.

Journal of cardiovascular development and disease·2026
Same author

Modulatory Effects of Polyphenols on Altered Leukocyte Functions in Thromboinflammation and Diabetes Mellitus.

International journal of molecular sciences·2026
Same author

International Society on Thrombosis and Haemostasis conflict of interest management and tools: presentation of a case study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

A Neutrophil-like Cell Model as Substitute for Human Neutrophils in NETs and Thrombosis Research.

Cells·2026
Same author

GPVI deficiency reduces clot size and murine thrombosis in normoglycaemic but not hyperglycemic conditions.

Platelets·2026
Same author

Fibrin-bound thrombin determines clot structure and blood thrombogenicity in normofibrinogenemia and dysfibrinogenemia.

Haematologica·2026

Related Experiment Video

Updated: Mar 20, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.9K

Novel mechanisms that regulate clot structure/function.

Robert A S Ariëns1

  • 1Thrombosis and Tissue Repair Group. Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Thrombosis Research
|May 22, 2016
PubMed
Summary
This summary is machine-generated.

Altered fibrin intrafibrillar structure, how protofibrils pack within fibers, impacts blood clot stability and thrombosis risk. Understanding this intrafibrillar structure is key to future research on bleeding and clotting disorders.

Keywords:
FXIIIThrombinclot structurefibrinfibrinogenintrafibrillar structure

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

12.1K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.4K

Related Experiment Videos

Last Updated: Mar 20, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

9.9K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

12.1K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

23.4K

Area of Science:

  • Biochemistry
  • Hematology
  • Biophysics

Background:

  • Blood clot structure and function are linked to thrombosis risk.
  • Dense fibrin networks with small pores elevate thrombosis risk by resisting fibrinolysis and altering clot viscoelasticity.
  • While overall fibrin network structure is well-studied, intrafibrillar structure remains poorly understood.

Purpose of the Study:

  • To review recent findings on mechanisms regulating fibrin intrafibrillar structure.
  • To discuss the functional consequences of intrafibrillar structure, including protofibril packing.
  • To examine the effects of Factor XIII (FXIII) activation on clot structure and thrombosis.

Main Methods:

  • Literature review of recent findings on fibrin structure and function.
  • Analysis of mechanisms influencing protofibril packing within fibrin fibers.
  • Examination of FXIII activation's role in clot formation and stability.

Main Results:

  • Fibrin intrafibrillar structure, specifically protofibril packing, is a novel determinant of clot structure and stability.
  • The arrangement of protofibrils within fibrin fibers significantly impacts clot properties.
  • FXIII activation influences fibrin clot structure and thrombosis.

Conclusions:

  • Fibrin intrafibrillar structure is a critical factor influencing blood clot characteristics.
  • Further research is needed to elucidate the role of intrafibrillar structure in clot function and in thrombotic and bleeding diseases.